• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconDrugs

Drugs

Page 30 of 32
Silk Road mastermind pleads for light sentence
Retail
Silk Road mastermind pleads for light sentence
By Benjamin SnyderMay 27, 2015
Biopharma deals are booming this year with no end in sight
Finance
Biopharma deals are booming this year with no end in sight
By Laura LorenzettiMay 8, 2015
J&J brings in ethicists to judge on requests for experimental drugs
Features
J&J brings in ethicists to judge on requests for experimental drugs
By ReutersMay 7, 2015
Inside of a Gilead Sciences Lab
Tech
Drugmaker Alexion boosts its rare drug pipeline with $8.4 billion deal
By ReutersMay 6, 2015
PA: Mylan Headquarters
Finance
Mylan goes big with $29 billion offer to buy Perrigo
By Laura LorenzettiApril 8, 2015
States ask U.S. Congress to launch inquiry of herbal supplements
Retail
States ask U.S. Congress to launch inquiry of herbal supplements
By ReutersApril 2, 2015
IL: Corporations In Illinois
Features
Takeda’s ready to shell out $2.2 billion to settle Actos drug cases
By Laura LorenzettiApril 1, 2015
Where do CEOs with addictions go when they hit bottom?
Leadership
Where do CEOs with addictions go when they hit bottom?
By Daniel BukszpanMarch 25, 2015
Merck
Features
Merck halts study in light of melanoma drug’s success
By Laura LorenzettiMarch 24, 2015
George Scangos, CEO of Biogen Inc. speaks during Reuters Health Summit in New York
Features
How Biogen scored the most successful Alzheimer’s drug so far
By Jen WiecznerMarch 20, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
Finance
Valeant comes out a winner after upping its Salix bid to $11.1 billion
By Laura LorenzettiMarch 16, 2015
Logo of Swiss drugmaker Novartis is seen at its headquarters in Basel
Features
FDA approves the first biosimilar for the U.S. market
By Laura LorenzettiMarch 6, 2015
IL: Corporations In Illinois
Finance
AbbVie to buy cancer drug maker Pharmacyclics in $21 billion deal
By ReutersMarch 4, 2015
Inside Rite Aid Ahead of Earnings Reports
Retail
Rite Aid takes aim at CVS with a $2 billion purchase
By Laura LorenzettiFebruary 11, 2015
161135392
Features
Biosimilars may one day save your life. But what are they?
By Laura LorenzettiFebruary 6, 2015
1...
  • 28
  • 29
  • 30
  • 31
  • 32
32
Most Popular
North America
Pentagon orders bases to plan for 90 days without the grid as Britain urges families to stockpile food and waterplaceholder alt text
By Bilin LinOctober 26, 2026
Success
Despite a $150 million net worth, Quentin Tarantino refuses to give a ‘penny’ of his fortune to his mother: ‘No house, no Cadillac’placeholder alt text
By Orianna Rosa RoyleOctober 28, 2026
Economy
For the first time since 1992, a Fed governor and president dissented together, as Kevin Warsh says the 'monetary medicine' is starting to workplaceholder alt text
By Catherina GioinoOctober 28, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.